Gain Therapeutics, Inc. Common Stock (GANX)

Typically moves ±3.02% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Since Nov 12, 2021, Gain Therapeutics, Inc. Common Stock (GANX) has reported earnings 20 times. On average the shares move ±3.02% post-earnings, with a positive reaction 55.0% of the time. Its largest post-earnings gain was +8.46% (Nov 12, 2021) and its largest decline was -8.09% (Mar 27, 2025). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How GANX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.02%

Positive %

55.0%

Negative %

45.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	+3.4%	open_in_new
May 11, 2026	☽ POST	-1.09%	open_in_new
Mar 26, 2026	☽ POST	-3.7%	open_in_new
Nov 12, 2025	☽ POST	+0.85%	open_in_new
Aug 12, 2025	☽ POST	+1.95%	open_in_new
May 14, 2025	☽ POST	-3.74%	open_in_new
Mar 27, 2025	☽ POST	-8.09%	open_in_new
Nov 14, 2024	☽ POST	+7.16%	open_in_new
Aug 08, 2024	☽ POST	+2.06%	open_in_new
May 14, 2024	☽ POST	+5.51%	open_in_new
Mar 26, 2024	☽ POST	-3.01%	open_in_new
Nov 14, 2023	☽ POST	+0%	open_in_new
Aug 10, 2023	☽ POST	-0.56%	open_in_new
May 12, 2023	☀ PRE	-0.97%	open_in_new
Mar 23, 2023	☽ POST	-0.62%	open_in_new
Nov 10, 2022	☽ POST	+0%	open_in_new
Aug 08, 2022	☀ PRE	+4.55%	open_in_new
May 16, 2022	☽ POST	-1.87%	open_in_new
Mar 24, 2022	☀ PRE	+2.72%	open_in_new
Nov 12, 2021	☀ PRE	+8.46%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.02%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 8 →

Funds holding

$1792290

Total value held

Flat

3 added · 3 reduced

Blackrock, Inc.

$558163 +22.18%

Ubs Group Ag

$436475 NEW BUY

State Street Corp

$319800 Held

Morgan Stanley

$255723 -9.80%

Northern Trust Corp

$196936 -14.90%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20261001	open_in_new SEC.gov
8-K	20260928	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov
4	20260717	open_in_new SEC.gov

Frequently asked about GANX earnings

When does Gain Therapeutics, Inc. Common Stock report earnings next? expand_more

Gain Therapeutics, Inc. Common Stock (GANX)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GANX stock move after earnings? expand_more

Over 20 reports, GANX has moved an average of ±3.02% the session after earnings, closing higher 55.0% of the time.

What was GANX's biggest post-earnings move? expand_more

GANX's largest post-earnings gain on record was +8.46% on Nov 12, 2021, and its largest decline was -8.09% on Mar 27, 2025.

Where can I find Gain Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Gain Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.